Entero Therapeutics's total assets for Q4 2024 were $85.41M, a decrease of -0.48% from the previous quarter. ENTO total liabilities were $27.61M for the fiscal quarter, a 75.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.